Eli Lilly's COVID-19 treatment
GPTKB entity
Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:administered_by |
intravenous infusion
|
| gptkbp:approves |
gptkb:FDA
November 2020 |
| gptkbp:availability |
hospital settings
outpatient settings |
| gptkbp:clinical_trial |
gptkb:Europe
gptkb:Canada gptkb:United_States thousands diverse demographics Phase 3 various age groups high-risk populations positive outcomes decreased mortality rates improved recovery time reduced viral load |
| gptkbp:collaborated_with |
Ab Cellera
|
| gptkbp:developed_by |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:distribution_channels |
hospitals
pharmacies health clinics |
| gptkbp:eligibility |
high-risk patients
mild to moderate COVID-19 |
| gptkbp:feedback |
generally positive
some concerns about side effects |
| gptkbp:funding |
government grants
private investments |
| gptkbp:future_prospects |
long-term effects
combination therapies new variants efficacy |
| https://www.w3.org/2000/01/rdf-schema#label |
Eli Lilly's COVID-19 treatment
|
| gptkbp:is_effective_against |
reduces hospitalization rates
|
| gptkbp:marketed_as |
gptkb:Bamlanivimab
|
| gptkbp:mechanism_of_action |
neutralizes virus
|
| gptkbp:media_coverage |
extensive
|
| gptkbp:part_of |
COVID-19 therapeutic options
|
| gptkbp:partnership |
government agencies
healthcare providers |
| gptkbp:price |
varies by location
|
| gptkbp:provides_guidance_on |
WHO recommendations
CDC recommendations |
| gptkbp:public_reaction |
mixed reviews
|
| gptkbp:regulatory_compliance |
emergency use authorization
conditional approval |
| gptkbp:research_focus |
COVID-19 variants
|
| gptkbp:side_effect |
fatigue
headache nausea diarrhea infusion reactions improves patient outcomes reduces burden on hospitals |
| gptkbp:suitable_for |
severe COVID-19 patients
|
| gptkbp:supply_chain |
global distribution
|
| gptkbp:targets |
gptkb:SARS-Co_V-2
|
| gptkbp:type |
gptkb:monoclonal_antibody
|
| gptkbp:used_for |
treatment of COVID-19
|
| gptkbp:bfsParent |
gptkb:Lonza_Group
|
| gptkbp:bfsLayer |
6
|